[ {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U",
    "@type" : [ "http://www.nanopub.org/nschema#Nanopublication" ],
    "http://www.nanopub.org/nschema#hasAssertion" : [ {
      "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion"
    } ],
    "http://www.nanopub.org/nschema#hasProvenance" : [ {
      "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#provenance"
    } ],
    "http://www.nanopub.org/nschema#hasPublicationInfo" : [ {
      "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#pubinfo"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#Head"
}, {
  "@graph" : [ {
    "@id" : "http://purl.obolibrary.org/obo/DOID_1588",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Disease"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#association",
    "@type" : [ "http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement" ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#object" : [ {
      "@id" : "http://purl.obolibrary.org/obo/DOID_1588"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate" : [ {
      "@id" : "https://w3id.org/biolink/vocab/treats"
    } ],
    "http://www.w3.org/1999/02/22-rdf-syntax-ns#subject" : [ {
      "@id" : "https://identifiers.org/drugbank:DB01109"
    } ],
    "http://www.w3.org/2000/01/rdf-schema#label" : [ {
      "@value" : "\"The use of Heparin Sodium in 0.45% Sodium Chloride Injection or Heparin Sodium in 5% Dextrose Injection is contraindicated in patients with the following conditions:   History of Heparin-Induced Thrombocytopenia (HIT) and Heparin-Induced Thrombocytopenia and Thrombosis (HITT)  [see Warnings and Precautions (  5.3 Known hypersensitivity to heparin or pork products (e.g., anaphylactoid reactions)  [see Adverse Reactions (  6.1 In whom suitable blood coagulation tests -- e.g., the whole blood clotting time, partial thromboplastin time, etc., -- cannot be performed at appropriate intervals (this contraindication refers to full-dose heparin; there is usually no need to monitor coagulation parameters in patients receiving low-dose heparin)  [see Warnings and Precautions (  5.5 An uncontrolled bleeding state  [see Warnings and Precautions (  5.2   History of Heparin-Induced Thrombocytopenia (HIT) and Heparin-Induced Thrombocytopenia and Thrombosis (HITT) (  4 Known hypersensitivity to heparin or pork products (  4 In whom suitable blood coagulation tests cannot be performed at appropriate intervals (  4\""
    } ],
    "https://w3id.org/biolink/vocab/provided_by" : [ {
      "@id" : "https://w3id.org/um/NeuroDKG"
    } ],
    "https://w3id.org/biolink/vocab/relation" : [ {
      "@id" : "https://schema.org/MedicalContraindication"
    } ]
  }, {
    "@id" : "https://identifiers.org/drugbank:DB01109",
    "https://w3id.org/biolink/vocab/category" : [ {
      "@id" : "https://w3id.org/biolink/vocab/Drug"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#assertion",
    "http://www.w3.org/ns/prov#wasAttributedTo" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#provenance"
}, {
  "@graph" : [ {
    "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U",
    "http://purl.org/dc/terms/created" : [ {
      "@type" : "http://www.w3.org/2001/XMLSchema#dateTime",
      "@value" : "2021-08-23T18:57:43.341+02:00"
    } ],
    "http://purl.org/dc/terms/creator" : [ {
      "@id" : "https://orcid.org/0000-0002-1468-3557"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate" : [ {
      "@id" : "http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate" : [ {
      "@id" : "http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM"
    } ],
    "https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate" : [ {
      "@id" : "http://purl.org/np/RAhNHZw6Urw_Mccs4qy6Ws3C9CRuaHpQx8AwuApbWkqnY"
    } ]
  }, {
    "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#sig",
    "http://purl.org/nanopub/x/hasAlgorithm" : [ {
      "@value" : "RSA"
    } ],
    "http://purl.org/nanopub/x/hasPublicKey" : [ {
      "@value" : "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB"
    } ],
    "http://purl.org/nanopub/x/hasSignature" : [ {
      "@value" : "BFfWhquQcweGbbmG3CXU8oZvIQBybUOWUtk1EdkcsogC6s9C+k/IT4m/+KuuGGMX6yntISm/TM4HeF/Mq9z1j8eNiyFwgSt+4+qS0PTSd1lbl7X+yyDUFurTwqvhxKRwfCjQ3pjFBSsbIZTmGOm5XFI+m5SNYm0vPp5Jowu0GTU="
    } ],
    "http://purl.org/nanopub/x/hasSignatureTarget" : [ {
      "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U"
    } ]
  } ],
  "@id" : "http://purl.org/np/RAT-7sbTFVfj7swAEk5DX7O8nCKBJSIcS0E9OoXwNDn8U#pubinfo"
} ]